Constitutively active mutations in RET cause the hereditary cancer syndromes multiple endocrine neoplasia type 2 (MEN2A and MEN2B) and familial medullary thyroid carcinoma. The gene discussed is RET; the disease is multiple endocrine neoplasia type 2.